Examining rare and low-frequency genetic variants previously associated with lone or familial forms of atrial fibrillation in an electronic medical record system: A cautionary note

Circulation: Cardiovascular Genetics

Volumn 8, Issue 1, 2015, Pages 58-63

  Weeke, Peter ^a,b   Denny, Joshua C ^a   Basterache, Lisa ^a   Shaffer, Christian ^a   Bowton, Erica ^c   Ingram, Christie ^a   Darbar, Dawood ^a   Roden, Dan M ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atrial fibrillation; Exome; Genetic association studies; Genetics; Genome wide association study; Polymorphism, single nucleotide

Indexed keywords

ADULT; AGED; ARTICLE; ELECTRONIC MEDICAL RECORD; EXOME; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC VARIABILITY; GENOTYPE; HEART ATRIUM FIBRILLATION; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ATRIAL FIBRILLATION; BLACK PERSON; COHORT ANALYSIS; FACTUAL DATABASE; GENETICS; REGISTER; VERY ELDERLY;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; COHORT STUDIES; DATABASES, FACTUAL; ELECTRONIC HEALTH RECORDS; FEMALE; HUMANS; MALE; REGISTRIES;

EID: 84924623150     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.114.000718     Document Type: Article

References (38)

1. Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med. 2002;113:359-364.
2. Darbar D, Kannankeril PJ, Donahue BS, Kucera G, Stubblefield T, Haines JL, et al. Cardiac sodium channel (SCN5A) variants associated with atrial fibrillation. Circulation. 2008;117:1927-1935. doi:10.1161/CIRCULATIONAHA.107.757955.
3. Xia M, Jin Q, Bendahhou S, He Y, Larroque MM, Chen Y, et al. A Kir2.1 gain-of-function mutation underlies familial atrial fibrillation. Biochem Biophys Res Commun. 2005;332:1012-1019. doi:10.1016/j.bbrc.2005.05.054.
4. Posch MG, Boldt LH, Polotzki M, Richter S, Rolf S, Perrot A, et al. Mutations in the cardiac transcription factor GATA4 in patients with lone atrial fibrillation. Eur J Med Genet. 2010;53:201-203. doi:10.1016/j.ejmg.2010.03.008.
5. Delaney JT, Muhammad R, Blair MA, Kor K, Fish FA, Roden DM, et al. A KCNJ8 mutation associated with early repolarization and atrial fibrillation. Europace. 2012;14:1428-1432. doi:10.1093/europace/eus150.
6. Medeiros-Domingo A, Tan BH, Crotti L, Tester DJ, Eckhardt L, Cuoretti A, et al. Gain-of-function mutation S422L in the KCNJ8-encoded cardiac K(ATP) channel Kir6.1 as a pathogenic substrate for J-wave syndromes. Heart Rhythm. 2010;7:1466-1471. doi:10.1016/j.hrthm.2010.06.016.
7. Abraham RL, Yang T, Blair M, Roden DM, Darbar D. Augmented potassium current is a shared phenotype for two genetic defects associated with familial atrial fibrillation. J Mol Cell Cardiol. 2010;48:181-190. doi:10.1016/j.yjmcc.2009.07.020.
8. Olesen MS, Yuan L, Liang B, Holst AG, Nielsen N, Nielsen JB, et al. High prevalence of long QT syndrome-associated SCN5A variants in patients with early-onset lone atrial fibrillation. Circ Cardiovasc Genet. 2012;5:450-459. doi:10.1161/CIRCGENETICS.111.962597.
9. Mann SA, Otway R, Guo G, Soka M, Karlsdotter L, Trivedi G, et al. Epistatic effects of potassium channel variation on cardiac repolarization and atrial fibrillation risk. J Am Coll Cardiol. 2012;59:1017-1025.doi:10.1016/j.jacc.2011.11.039.
10. Müller II, Melville DB, Tanwar V, Rybski WM, Mukherjee A, Shoemaker MB, et al. Functional modeling in zebrafish demonstrates that the atrial-fibrillation-associated gene GREM2 regulates cardiac laterality, cardiomyocyte differentiation and atrial rhythm. Dis Model Mech. 2013;6:332-341. doi:10.1242/dmm.010488.
11. Olson TM, Michels VV, Ballew JD, Reyna SP, Karst ML, Herron KJ, et al. Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. JAMA. 2005;293:447-454. doi:10.1001/jama.293.4.447.
12. Weeke P, Muhammad R, Delaney JT, Shaffer C, Mosley JD, Blair M, et al; National Heart, Lung, and Blood Institute (NHLBI) GO Exome Sequencing Project. Whole-exome sequencing in familial atrial fibrillation. Eur Heart J. 2014;35:2477-2483. doi:10.1093/eurheartj/ehu156.
13. Ellinor PT, Lunetta KL, Glazer NL, Pfeufer A, Alonso A, Chung MK, et al. Common variants in KCNN3 are associated with lone atrial fibrillation. Nat Genet. 2010;42:240-244. doi:10.1038/ng.537.
14. Ellinor PT, Lunetta KL, Albert CM, Glazer NL, Ritchie MD, Smith AV, et al. Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet. 2012;44:670-675. doi:10.1038/ng.2261.
15. Pfeufer A, van Noord C, Marciante KD, Arking DE, Larson MG, Smith AV, et al. Genome-wide association study of PR interval. Nat Genet. 2010;42:153-159. doi:10.1038/ng.517.
16. Benjamin EJ, Rice KM, Arking DE, Pfeufer A, van Noord C, Smith AV, et al. Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry. Nat Genet. 2009;41:879-881. doi:10.1038/ng.416.
17. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, et al. Finding the missing heritability of complex diseases. Nature. 2009;461:747-753. doi:10.1038/nature08494.
18. Roden DM, Pulley JM, Basford MA, Bernard GR, Clayton EW, Balser JR, et al. Development of a large-scale de-identified DNA biobank to enable personalized medicine. Clin Pharmacol Ther. 2008;84:362-369. doi:10.1038/clpt.2008.89.
19. Bowton E, Field JR, Wang S, Schildcrout JS, Van Driest SL, Delaney JT, et al. Biobanks and electronic medical records: enabling cost-effective research. Sci Transl Med. 2014;6:234cm3. doi:10.1126/scitranslmed.3008604.
20. Ritchie MD, Denny JC, Crawford DC, Ramirez AH, Weiner JB, Pulley JM, et al. Robust replication of genotype-phenotype associations across multiple diseases in an electronic medical record. Am J Hum Genet. 2010;86:560-572. doi:10.1016/j.ajhg.2010.03.003.
21. Patterson N, Price AL, Reich D. Population structure and eigenanalysis. PLoS Genet. 2006;2:e190. doi:10.1371/journal.pgen.0020190.
22. Olesen MS, Nielsen MW, Haunsø S, Svendsen JH. Atrial fibrillation: the role of common and rare genetic variants. Eur J Hum Genet. 2014;22:297-306. doi:10.1038/ejhg.2013.139.
23. Gudbjartsson DF, Holm H, Gretarsdottir S, Thorleifsson G, Walters GB, Thorgeirsson G, et al. A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke. Nat Genet. 2009;41:876-878. doi:10.1038/ng.417.
24. Arnestad M, Crotti L, Rognum TO, Insolia R, Pedrazzini M, Ferrandi C, et al. Prevalence of long-QT syndrome gene variants in sudden infant death syndrome. Circulation. 2007;115:361-367. doi:10.1161/CIRCULATIONAHA.106.658021.
25. Tennessen JA, Bigham AW, O'Connor TD, Fu W, Kenny EE, Gravel S, et al; Broad GO; Seattle GO; NHLBI Exome Sequencing Project. Evolution and functional impact of rare coding variation from deep sequencing of human exomes. Science. 2012;337:64-69. doi:10.1126/science.1219240.
26. Weeke P, Mosley JD, Hanna D, Delaney JT, Shaffer C, Wells QS, et al. Exome sequencing implicates an increased burden of rare potassium channel variants in the risk of drug-induced long QT interval syndrome. J Am Coll Cardiol. 2014;63:1430-1437. doi:10.1016/j.jacc.2014.01.031.
27. Ritchie MD, Rowan S, Kucera G, Stubblefield T, Blair M, Carter S, et al. Chromosome 4q25 variants are genetic modifiers of rare ion channel mutations associated with familial atrial fibrillation. J Am Coll Cardiol. 2012;60:1173-1181. doi:10.1016/j.jacc.2012.04.030.
28. Weeke P, Parvez B, Blair M, Short L, Ingram C, Kucera G, et al. Candidate gene approach to identifying rare genetic variants associated with lone atrial fibrillation. Heart Rhythm. 2014;11:46-52. doi:10.1016/j.hrthm.2013.10.025.
29. Olson TM, Alekseev AE, Moreau C, Liu XK, Zingman LV, Miki T, et al. KATP channel mutation confers risk for vein of Marshall adrenergic atrial fibrillation. Nat Clin Pract Cardiovasc Med. 2007;4:110-116. doi:10.1038/ncpcardio0792.
30. Ploski R, Pollak A, Müller S, Franaszczyk M, Michalak E, Kosinska J, et al. Does p.Q247X in TRIM63 cause human hypertrophic cardiomyopathy? Circ Res. 2014;114:e2-e5. doi:10.1161/CIRCRESAHA.114.302662.
31. Chen SN, Czernuszewicz G, Tan Y, Lombardi R, Jin J, Willerson JT, et al. Human molecular genetic and functional studies identify TRIM63, encoding Muscle RING Finger Protein 1, as a novel gene for human hypertrophic cardiomyopathy. Circ Res. 2012;111:907-919. doi:10.1161/CIRCRESAHA.112.270207.
32. Jabbari J, Jabbari R, Nielsen MW, Holst AG, Nielsen JB, Haunsø S, et al. New exome data question the pathogenicity of genetic variants previously associated with catecholaminergic polymorphic ventricular tachycardia. Circ Cardiovasc Genet. 2013;6:481-489. doi:10.1161/CIRCGENETICS.113.000118.
33. Risgaard B, Jabbari R, Refsgaard L, Holst AG, Haunsø S, Sadjadieh A, et al. High prevalence of genetic variants previously associated with Brugada syndrome in new exome data. Clin Genet. 2013;84:489-495. doi:10.1111/cge.12126.
34. Andreasen C, Nielsen JB, Refsgaard L, Holst AG, Christensen AH, Andreasen L, et al. New population-based exome data are questioning the pathogenicity of previously cardiomyopathy-associated genetic variants. Eur J Hum Genet. 2013;21:918-928. doi:10.1038/ejhg.2012.283.
35. Norton N, Li D, Rampersaud E, Morales A, Martin ER, Zuchner S, et al; National Heart, Lung, and Blood Institute GO Exome Sequencing Project and the Exome Sequencing Project Family Studies Project Team. Exome sequencing and genome-wide linkage analysis in 17 families illustrate the complex contribution of TTN truncating variants to dilated cardiomyopathy. Circ Cardiovasc Genet. 2013;6:144-153. doi:10.1161/CIRCGENETICS.111.000062.
36. Lange LA, Hu Y, Zhang H, Xue C, Schmidt EM, Tang ZZ, et al NHLBI Grand Opportunity Exome Sequencing Project. Whole-exome sequencing identifies rare and low-frequency coding variants associated with LDL cholesterol. Am J Hum Genet. 2014;94:233-245. doi:10.1016/j.ajhg.2014.01.010.
37. Peloso GM, Auer PL, Bis JC, Voorman A, Morrison AC, Stitziel NO, et al; NHLBI GO Exome Sequencing Project. Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 whites and blacks. Am J Hum Genet. 2014;94:223-232. doi:10.1016/j.ajhg.2014.01.009.
38. Auer PL, Teumer A, Schick U, O'Shaughnessy A, Lo KS, Chami N, et al. Rare and low-frequency coding variants in CXCR2 and other genes are associated with hematological traits. Nat Genet. 2014;46:629-634. doi:10.1038/ng.2962.